Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sheel Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SHEEL

₹58.75

₹0.00 (0.00%)

As on 28-Aug-2026 12:06IST

Market cap

info icon

₹120 Cr

Revenue (TTM)

info icon

₹102 Cr

P/E Ratio

info icon

10.2

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 10.26 12.88 10.79
EBIT -- -- 4.49 37.26 19.16
Net Profit -- -- 1.54 33.11 19.20
EPS -- -- -1.51 31.76 18.48
Book Value -- -- 11.89 10.83 9.07
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 12.7210.9913.8314.599.75
Net Margin info 9.358.4010.4011.326.33
Return on equity info 12.4010.7413.5915.388.24
Return on Capital info 13.2110.9714.7815.359.50
Return on Assets info 8.547.339.7110.495.43
Debt to Equity (x) info ----0.210.320.30

Profitability

View Detailed Peer Comparison

ROCE

14.78

Lower than Peers by 7.01

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
14.78
15.35
9.50
7.16
8.05
Peer Median
21.79
0.14
--
--
--
ROE

13.59

Lower than Peers by 2.58

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
13.59
15.38
8.24
7.75
8.77
Peer Median
16.17
0.10
--
--
--
ROA

9.71

Lower than Peers by 2.45

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
9.71
10.49
5.43
5.14
5.86
Peer Median
12.16
0.09
--
--
--
EBIT Margin

13.83

Higher than Peers by 0.36

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
13.83
14.59
9.75
7.69
9.11
Peer Median
13.47
8.33
--
--
--
Net Margin

10.40

Lower than Peers by 0.81

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
10.40
11.32
6.33
6.35
7.59
Peer Median
11.21
9.71
--
--
--
Cash Profit Margin

11.34

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
11.34
12.42
7.61
7.71
8.81
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

10.26

Lower than Peers by 4.96

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
10.26
15.19
13.26
12.23
3.41
Peer Median
15.22
--
--
--
--
EBIT Growth

4.49

Lower than Peers by 2,879.65

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
4.49
72.39
43.57
-5.20
-2.01
Peer Median
2,884.14
356.94
--
--
--
Net Profit Growth

1.54

Higher than Peers by 10.99

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
1.54
106.34
12.56
-5.99
8.55
Peer Median
-9.45
900.00
--
--
--
EPS Growth

-1.51

Higher than Peers by 27.22

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
-1.51
106.34
12.56
-5.99
8.55
Peer Median
-28.73
--
--
--
--
Book Value Growth

15.36

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
15.36
14.40
6.35
5.35
7.65
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.21

Higher than Peers by 0.17

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
0.21
0.32
0.30
0.39
0.37
Peer Median
0.04
0.03
--
--
--
Short term debt to equity ratio

0.15

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
0.15
0.18
0.12
0.15
0.15
Peer Median
--
--
--
--
--
Current Ratio

4.21

Higher than Peers by 0.28

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
4.21
4.22
4.04
4.25
5.52
Peer Median
3.93
6.31
--
--
--
Quick Ratio

2.57

Lower than Peers by 1.24

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
2.57
2.77
3.10
3.65
5.05
Peer Median
3.81
3.62
--
--
--
Interest Coverage

8.26

Lower than Peers by 17.33

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
8.26
9.28
5.19
4.90
5.12
Peer Median
25.59
51.60
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

54.13

Higher than Peers by 29.59

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
54.13
62.53
69.96
91.48
96.28
Peer Median
24.55
23.00
--
--
--
Asset Turnover

0.93

Lower than Peers by 2.26

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
0.93
0.92
0.86
0.81
0.77
Peer Median
3.19
3.90
--
--
--
Receivable days

202.28

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
202.28
224.95
275.07
323.52
339.04
Peer Median
--
--
--
--
--
Inventory Days

129.42

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
129.42
102.98
70.91
46.71
42.74
Peer Median
--
--
--
--
--
Payable days

24.48

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
24.48
40.99
56.91
45.45
64.57
Peer Median
--
--
--
--
--
Cash Conversion Cycle

307.22

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
307.22
286.95
289.07
324.77
317.20
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
--
--
--
--
--
Peer Median
17.42
21.56
--
--
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
--
--
--
--
--
Peer Median
2.59
3.43
--
--
--
EV/EBITDA

2.06

Lower than Peers by 8.23

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
2.06
1.84
2.59
4.08
3.70
Peer Median
10.28
-11.31
--
--
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Sheel Biotech
--
--
--
--
--
Peer Median
23
29
--
--
--
loading...
loading...
loading...